RENELIT Trademark

Trademark Overview


On Friday, February 13, 2009, a trademark application was filed for RENELIT with the United States Patent and Trademark Office. The USPTO has given the RENELIT trademark a serial number of 77670243. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Thursday, October 29, 2009. This trademark is owned by Pfizer Inc.. The RENELIT trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, HIV/AIDS, Alzheimer's Disease and Huntington's Disease; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines
renelit

General Information


Serial Number77670243
Word MarkRENELIT
Filing DateFriday, February 13, 2009
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateThursday, October 29, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2009

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, HIV/AIDS, Alzheimer's Disease and Huntington's Disease; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, October 29, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Thursday, October 29, 2009ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Thursday, October 29, 2009ABANDONMENT - AFTER PUBLICATION
Wednesday, October 28, 2009TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, July 28, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 5, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 15, 2009NOTICE OF PUBLICATION
Wednesday, April 1, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 1, 2009ASSIGNED TO LIE
Wednesday, April 1, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 25, 2009ASSIGNED TO EXAMINER
Wednesday, February 18, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, February 18, 2009NEW APPLICATION ENTERED IN TRAM